NuPath, a higher-sensitivity TRUPATH-derived biosensor, expands detection of basal and agonist-induced GPCR activation.
NuPath is positioned as a robust, modular enhancement of TRUPATH for resolving agonist-driven, Gβγ-specific, and constitutive GPCR signalling.